Back to Stakeholders

Home to the Michigan Psychedelic Center (M-PsyC), a multidisciplinary initiative launched in 2022 by the University of Michigan to advance psychedelic science with rigor and responsibility. M-PsyC conducts clinical trials on psilocybin for fibromyalgia and depression, and DMT research, spanning neuroscience, psychiatry, pharmacology, and nursing.

Quick Facts

Type
Other
HQ
United States
Website
Visit